Myasthenia gravis patients show higher rates of dysarthria, dysphonia, dysphagia, and aspiration pneumonia compared to non-affected individuals. Despite high disorder rates, most myasthenia gravis ...

Argenx is a hold due to limited catalysts in 2025, a rich valuation and clinical risk around label expansion. Read more about ...

TG Therapeutics, Inc. (NASDAQ:TGTX) stock is surging today. This is one of the few biotechs that we owned from a more developmental stage company into one that is now generating substantial ...

This guidance is for healthcare professionals who care for women ... It is also under investigation for other autoimmune conditions such as myasthenia gravis. In the UNITY trial, 13 women at high risk ...

A new consensus paper provides an updated evaluation of reference bone turnover markers (BTMs) and newer markers in the ...

This CME program is designed to enhance neurologists' understanding and management of generalized myasthenia gravis (gMG). Participants will explore how comprehensive assessment of disease burden ...

Nicholas J. Silvestri, MD, expects that the upcoming 2025 American Academy of Neurology Annual Meeting in San Diego will be an exciting event for the field of myasthenia gravis (MG), with ...

A sustained-release form of pyridostigmine bromide (Mestinon Timespan) has been in use since 1956. This is a scored, slowly-absorbable tablet containing 180 mg. of pyridostigmine bromide or the ...

Opens in a new tab or window Generalized myasthenia gravis (gMG) affects most patients ... of differences among patients affect the clinical management of the disease burden, which manifests ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.

Massachusetts colleges and universities are doubling down on guidance to international students in the wake of immigration-related executive actions from the Trump administration. Schools like ...